4.6 Article

Regulation of DNA damage responses and cell cycle progression by hMOB2

期刊

CELLULAR SIGNALLING
卷 27, 期 2, 页码 326-339

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2014.11.016

关键词

DNA damage response signalling; Mps one binder 2; Cell cycle progression; p53 tumour suppressor protein; Cell cycle checkpoint activation; MRE11-RAD50-NBS1 protein complex

资金

  1. AICR [11-0634]
  2. Ministry of National Education (Republic of Turkey)
  3. BBSRC [BB/I021248/1]
  4. Wellcome Trust [090090/Z/09/Z]
  5. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  6. BBSRC [BB/I021248/1] Funding Source: UKRI
  7. Biotechnology and Biological Sciences Research Council [BB/I021248/1] Funding Source: researchfish
  8. Cancer Research UK [15394] Funding Source: researchfish
  9. Worldwide Cancer Research [11-0634] Funding Source: researchfish

向作者/读者索取更多资源

Mps one binder proteins (MOBS) are conserved regulators of essential signalling pathways. Biochemically, human MOB2 (hMOB2) can inhibit NDR kinases by competing with hMOB1 for binding to NDRs. However, biological roles of hMOB2 have remained enigmatic. Here, we describe novel functions of hMOB2 in the DNA damage response (DDR) and cell cycle regulation. hMOB2 promotes DDR signalling, cell survival and cell cycle arrest after exogenously induced DNA damage. Under normal growth conditions in the absence of exogenously induced DNA damage hMOB2 plays a role in preventing the accumulation of endogenous DNA damage and a subsequent p53/p21-dependent G1/S cell cycle arrest. Unexpectedly, these molecular and cellular phenotypes are not observed upon NDR manipulations, indicating that hMOB2 performs these functions independent of NDR signalling. Thus, to gain mechanistic insight, we screened for novel binding partners of hMOB2, revealing that hMOB2 interacts with RAD50, facilitating the recruitment of the MRE11-RAD5O-NBS1 (MRN) DNA damage sensor complex and activated ATM to DNA damaged chromatin. Taken together, we conclude that hMOB2 supports the DDR and cell cycle progression. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells

Valentina Maggio, Veronica Canovas, Alex J. Felix, Valenti Gomez, Ines de Torres, Maria Eugenia Semidey, Juan Morote, Veronique Noe, Carlos J. Ciudad, Rosanna Paciucci

CANCER LETTERS (2019)

Article Genetics & Heredity

Defective DNA Polymerase α-Primase Leads to X-Linked Intellectual Disability Associated with Severe Growth Retardation, Microcephaly, and Hypogonadism

Hilde Van Esch, Rita Colnaghi, Kathleen Freson, Petro Starokadomskyy, Andreas Zankl, Liesbeth Backx, Iga Abramowicz, Emily Outwin, Luis Rohena, Claire Faulkner, Gary M. Leong, Ruth A. Newbury-Ecob, Rachel C. Challis, Katrin Ounap, Jacques Jaeken, Eve Seuntjens, Koen Devriendt, Ezra Burstein, Karen J. Low, Mark O'Driscoll

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Article Genetics & Heredity

Somatic PDGFRB Activating Variants in Fusiform Cerebral Aneurysms

Yigit Karasozen, Joshua W. Osbun, Carolina Angelica Parada, Tina Busald, Philip Tatman, Luis F. Gonzalez-Cuyar, Christopher J. Hale, Diana Alcantara, Mark O'Driscoll, William B. Dobyns, Mitzi Murray, Louis J. Kim, Peter Byers, Michael O. Dorschner, Manuel Ferreira

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Review Cell Biology

MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer

Ramazan Gundogdu, Alexander Hergovich

Review Pharmacology & Pharmacy

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches

Valenti Gomez, Rami Mustapha, Kenrick Ng, Tony Ng

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

The Effect of TIGAR Knockdown on Apoptotic and Epithelial-Mesenchymal Markers Expression in Doxorubicin-Resistant Non-Small Cell Lung Cancer A549 Cell Lines

Can Ali Agca, Mahinur Kirici, Victor S. Nedzvetsky, Ramazan Gundogdu, Artem A. Tykhomyrov

CHEMISTRY & BIODIVERSITY (2020)

Article Biochemistry & Molecular Biology

Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells

Valenti Gomez, Thomas R. Eykyn, Rami Mustapha, Fabian Flores-Borja, Victoria Male, Paul R. Barber, Antonia Patsialou, Ryan Green, Fani Panagaki, Chun W. Li, Gilbert O. Fruhwirth, Susana Ros, Kevin M. Brindle, Tony Ng

SCIENCE SIGNALING (2020)

Article Biochemistry & Molecular Biology

Fatty acid composition, enzyme inhibitory effect, antioxidant and anticancer activity of extract from Saponaria prostrata WILLD. subsp. anatolica HEDGE

Mehmet Kadir Erdogan, Ibrahim Halil Gecibesler, Yakup Yapar, Ramazan Gundogdu, Mahinur Kirici, Lutfi Behcet, Parham Taslimi

Summary: The study evaluated the antioxidant, enzyme inhibitory, and anticancer properties of endemic Saponaria prostrata subsp. anatolica. Results showed that the plant exhibited promising acetylcholinesterase, butyrylcholinesterase, and alpha-glycosidase inhibitory activities, as well as significant anticancer effects on breast and colorectal cancer cell lines.

BIOORGANIC CHEMISTRY (2021)

Article Toxicology

Royal jelly abrogates flouride-induced oxidative damage in rat heart tissue by activating of the nrf-2/NF-κB and bcl-2/bax pathway

Abdullah Aslan, Seda Beyaz, Ozlem Gok, Muhammed Ismail Can, Gozde Parlak, Ibrahim Hanifi Ozercan, Ramazan Gundogdu

Summary: In this study, it was found that royal jelly can reduce lipid peroxidation and certain protein expression levels in heart tissue, while increasing the expression levels of some proteins, indicating its potential therapeutic effect on heart diseases.

TOXICOLOGY MECHANISMS AND METHODS (2021)

Article Clinical Neurology

DTYMK is essential for genome integrity and neuronal survival

Jo M. Vanoevelen, Jorgen Bierau, Janine C. Grashorn, Ellen Lambrichs, Erik-Jan Kamsteeg, Levinus A. Bok, Ron A. Wevers, Marjo S. van der Knaap, Marianna Bugiani, Junmei Hu Frisk, Rita Colnaghi, Mark O'Driscoll, Debby M. E. Hellebrekers, Richard Rodenburg, Carlos R. Ferreira, Han G. Brunner, Arthur van den Wijngaard, Ghada M. H. Abdel-Salam, Liya Wang, Constance T. R. M. Stumpel

Summary: The study reveals that impairing the biosynthesis of dTTP, a crucial DNA building block, leads to early-onset neurodegenerative disease characterized by severe microcephaly and growth retardation. Microcephaly, neuronal cell death, and early lethality were replicated in dtymk mutant zebrafish models. Furthermore, increased ribonucleotide incorporation in the genome and impaired responses to DNA damage were observed in these mutant zebrafish, providing novel insights into the pathophysiology of the disease. The loss-of-function of DTYMK was identified as the cause of this severe postnatal neurodegenerative disease, emphasizing the essential role of dTTP synthesis in maintaining genome stability and neuronal survival.

ACTA NEUROPATHOLOGICA (2022)

Article Cell Biology

hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitors

Ramazan Gundogdu, M. Kadir Erdogan, Angeliki Ditsiou, Victoria Spanswick, Juan Jose Garcia-Gomez, John A. Hartley, Fumiko Esashi, Alexander Hergovich, Valenti Gomez

Summary: The study reveals that hMOB2 regulates double-strand break repair by homologous recombination, impacting the response of cancer cells to treatment. Loss of hMOB2 increases vulnerability of cancer cells to PARP inhibitors.

CELLULAR SIGNALLING (2021)

Review Biochemistry & Molecular Biology

RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription

Choon Ping Tan, Laura Sinigaglia, Valenti Gomez, Joanna Nicholls, Nagy A. Habib

Summary: RNA activation (RNAa) is a mechanism in which RNA oligos increase the transcription output of target genes, with small activating RNA (saRNA) representing a new class of therapeutic drugs to rescue downregulation of critical genes in diseases. MTL-CEBPA, a compound using CEBPA-51 saRNA to reverse downregulation in oncogenic processes, has entered clinical trials for hepatocellular carcinoma treatment, showing potential therapeutic effects.

MOLECULES (2021)

Article Anatomy & Morphology

Royal jelly regulates the caspase, Bax and COX-2, TNF-α protein pathways in the fluoride exposed lung damage in rats

Abdullah Aslan, Ozlem Gok, Seda Beyaz, Muhammed Ismail Can, Gozde Parlak, Ramazan Gundogdu, Ibrahim Hanifi Ozercan, Serpil Baspinar

Summary: The study found that royal jelly can reduce oxidative stress and inflammatory response caused by fluoride damage in rats. Royal jelly can decrease the degree of lung damage caused by fluoride and promote the repair and protection of lung tissue.

TISSUE & CELL (2022)

Article Allergy

Homozygous DBF4 mutation as a cause of severe congenital neutropenia

Mathijs Willemsen, John S. Barber, Erika Van Nieuwenhove, Frederik Staels, Margaux Gerbaux, Julika Neumann, Teresa Prezzemolo, Emanuela Pasciuto, Vasiliki Lagou, Nancy Boeckx, Jessica Filtjens, Amber De Visscher, Patrick Matthys, Rik Schrijvers, Thomas Tousseyn, Mark O'Driscoll, Giorgia Bucciol, Susan Schlenner, Isabelle Meyts, Stephanie Humblet-Baron, Adrian Liston

Summary: This study reported a patient with severe congenital neutropenia and syndromic features, and a homozygous missense mutation in the DBF4 gene was identified using whole exome sequencing. This mutation caused defects in granulocyte differentiation and DNA replication, resulting in impaired immune system function.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Cell Biology

DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway

Ke Mi, Lizhong Zeng, Yang Chen, Jingya Ning, Siyuan Zhang, Peilin Zhao, Shuanying Yang

Summary: In this study, the researchers explored the role of DHX38 in NSCLC and its underlying molecular mechanism. They found that DHX38 was overexpressed in NSCLC and patients with high DHX38 expression had poor prognosis. DHX38 promoted cell proliferation, migration, and invasion in NSCLC and activated the MAPK pathway. The researchers also identified G3BP1 as a target protein that interacted with DHX38 and showed that DHX38 regulated the expression of G3BP1. Silencing G3BP1 reversed the effects of DHX38 overexpression on tumor cell proliferation, migration, and invasion and inhibited the MAPK pathway activation.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Functional delineation of the luminal epithelial microenvironment in breast using cell-based screening in combinatorial microenvironments

Tiina A. Jokela, Mark A. Dane, Rebecca L. Smith, Kaylyn L. Devlin, Sundus Shalabi, Jennifer C. Lopez, Masaru Miyano, Martha R. Stampfer, James E. Korkola, Joe W. Gray, Laura M. Heiser, Mark A. Labarge

Summary: Microenvironment signals have a significant impact on cell fate and tissue homeostasis. Understanding how different microenvironment factors regulate cellular phenotype has been challenging. In this study, a high-throughput microenvironment microarray was used to identify factors that support the proliferation and maintenance of primary human mammary luminal epithelial cells. Multiple factors that modulate luminal cell number were identified and their effects were confirmed using RNA sequencing and cell-based functional studies. Hepatocyte growth factor (HGF) was found to be robust to individual variation and played a role in expanding luminal cells. Our approach demonstrates the power of high-dimensional cell-based approaches in dissecting microenvironmental signals.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Stem cell landscape aids in tumor microenvironment identification and selection of therapeutic agents in gastric cancer

Chao He, Yongfeng Ding, Yan Yang, Gang Che, Fei Teng, Haohao Wang, Jing Zhang, Donghui Zhou, Yanyan Chen, Zhan Zhou, Haiyong Wang, Lisong Teng

Summary: This study categorized gastric cancer patients into three stemness subtypes, each demonstrating distinct prognoses, components of tumor microenvironment (TME) infiltration, and varying sensitivity or resistance to treatment. A stemness risk model was constructed to predict treatment response and prognosis.

CELLULAR SIGNALLING (2024)

Article Cell Biology

miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma

Haile Zhao, Lijuan Feng, Rui Cheng, Man Wu, Xiaozhou Bai, Lifei Fan, Yaping Liu

Summary: miR-29c-3p is overexpressed in benign and malignant ovarian carcinoma and is associated with poor prognosis. Its overexpression modulates tumorigenesis in ovarian cancer cells, including epithelial-mesenchymal transition, proliferation, migration, and invasion, through the regulation of DNMT3A, TET1, and HBP1. miR-29c-3p may serve as a potential biomarker for clinical diagnosis or co-diagnosis of ovarian carcinoma.

CELLULAR SIGNALLING (2024)

Article Cell Biology

E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer

Haiyan Zhao, Fangfang Bi, Mengyuan Li, Yuhan Diao, Chen Zhang

Summary: This study confirmed the tumor suppressor effect of RNF180 on ovarian cancer, elucidated the mechanism of the molecule network related to RNF180 and IPO4 in ovarian cancer, and identified a new therapeutic target for ovarian cancer.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Decreased FoxO1 expression contributes to facet joint osteoarthritis pathogenesis by impairing chondrocyte migration and extracellular matrix synthesis

Chu Chen, Guanhua Xu, Jiajia Chen, Chunshuai Wu, Jinlong Zhang, Jiawei Jiang, Hongxiang Hong, Zhiming Cui

Summary: This study investigated the role of transcription factor FoxO1 in facet joint osteoarthritis (FJOA) and found that FoxO1 deletion led to severe osteoarthritic changes. Transcriptome sequencing and bioinformatics analysis identified differentially expressed genes (DEGs) and potential key contributors to FJOA. Additionally, over-expression of certain genes and inhibition of others were shown to counteract the impairments caused by FoxO1 deletion in chondrocyte migration and extracellular matrix synthesis. These findings help unravel the molecular mechanisms underlying FJOA and open up promising therapeutic avenues for its treatment.

CELLULAR SIGNALLING (2024)

Article Cell Biology

CircFSCN1 induces tumor progression and triggers epithelial-mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing

Wen Deng, Ru Chen, Situ Xiong, Jianqiang Nie, Hailang Yang, Ming Jiang, Bing Hu, Xiaoqiang Liu, Bin Fu

Summary: This study demonstrates that circFSCN1 is upregulated in bladder cancer and associated with cancer-specific survival. CircFSCN1 promotes tumor progression and epithelial-mesenchymal transition in bladder cancer through enhancing MDM2-mediated silencing of p53 by sponging miR-145-5p.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Knockdown of SQLE promotes CD8+T cell infiltration in the tumor microenvironment

Jun Wu, Weibin Hu, Wenhui Yang, Yihao Long, Kaizhao Chen, Fugui Li, Xiaodong Ma, Xun Li

Summary: Cholesterol biosynthesis and metabolism play critical roles in tumor development and microenvironmental conditions. Squalene Epoxidase (SQLE), the second rate-limiting enzyme in cholesterol synthesis, is found to be uniquely expressed in various cancers, and its expression level is closely associated with tumor mutation burden and microsatellite instability. SQLE expression is negatively correlated with immune cell infiltration. Inhibition of SQLE alters the immune response in the tumor microenvironment. Furthermore, protein metabolism and translation are identified as main binding factors with SQLE.

CELLULAR SIGNALLING (2024)

Article Cell Biology

ZNF70 regulates IL-1β secretion of macrophages to promote the proliferation of HCT116 cells via activation of NLRP3 inflammasome and STAT3 pathway in colitis-associated colorectal cancer

Zhihong Zhang, Mingyue Li, Yi Tai, Yue Xing, Hongxiang Zuo, Xuejun Jin, Juan Ma

Summary: ZNF70 plays an important role in colitis-associated colorectal cancer (CAC) by regulating macrophages IL-1 beta secretion to promote HCT116 proliferation. It may serve as a promising target for treating CAC.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Immune checkpoints signature-based risk stratification for prognosis of patients with gastric cancer

Zenghong Wu, Gangping Li, Weijun Wang, Kun Zhang, Mengke Fan, Yu Jin, Rong Lin

Summary: This study comprehensively explored the role of immune checkpoints and tumor microenvironment in gastric cancer patients based on genomic data. It constructed an ICIs signature and ICI score to evaluate patient prognosis and heterogeneity.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Inhibition of spinal Rac1 attenuates chronic inflammatory pain by regulating the activation of astrocytes

Yantong Wan, Jieshu Zhou, Panpan Zhang, Xuemei Lin, Hao Li

Summary: This study found that Rac1 plays a role in astrocyte activation and attenuates chronic inflammatory pain by blocking the phosphorylation of NLRP3 inflammasome and NF-kappa B.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1

Zhen Wang, Diankun She, Lei Liu, Xianming Hua, Hao Zhu, Lingfeng Yu, Han Wang, Yan Zhu, Gentao Fan, Yicun Wang, Meng Xu, Guangxin Zhou

Summary: Circular RNAs (circRNAs) are non-coding RNAs that play a role in the regulation of various cancers, including osteosarcoma (OS). This study identified circSATB2 as a highly expressed circRNA in OS tissues and cell lines, and demonstrated its involvement in promoting OS proliferation and migration. Mechanistically, circSATB2 was found to regulate the progression of OS by sponging miR-661 and FUS to regulate ZNFX1 mRNA. These findings suggest that circSATB2 could serve as a prognostic marker and therapeutic target for osteosarcoma.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Extracellular vesicles of iPS cells highly capable of producing HGF and TGF-β1 can attenuate Sjogren's syndrome via innate immunity regulation

Kenichi Ogata, Masafumi Moriyama, Tatsuya Kawado, Hiroki Yoshioka, Aiko Yano, Mayu Matsumura-Kawashima, Seiji Nakamura, Shintaro Kawano

Summary: This study found that extracellular vesicles released by induced pluripotent stem cells can reduce inflammatory cell infiltration, increase saliva volume, and decrease the production of antibodies associated with Sjogren's syndrome in a mouse model. The let-7 family in these vesicles may suppress the expression of TLR4 and NF-kappa B, which leads to the inhibition of pro-inflammatory cytokine production through the MAPK pathway.

CELLULAR SIGNALLING (2024)

Article Cell Biology

Phosphodiesterase 4 activity uniquely regulates ciliary cAMP-dependent 3T3-L1 adipogenesis

Mikayla R. Erdelsky, Sarah A. Groves, Charmi Shah, Samantha B. Delios, M. Bibiana Umana, Donald H. Maurice

Summary: Recent evidence suggests that cAMP signaling within the primary cilium plays a crucial role in promoting adipogenic differentiation of 3T3-L1 preadipocytes. In this study, the researchers identified the specific cAMP phosphodiesterases expressed by these cells and found that inhibition of PDE4 promotes FFAR4-mediated adipogenesis. This work could potentially lead to the discovery of more targeted therapeutic approaches for controlling adipogenesis and differentiation of other stem cells.

CELLULAR SIGNALLING (2024)

Article Cell Biology

METTL3 regulates the proliferation, metastasis and EMT progression of bladder cancer through P3H4

Chun-Hui Liu, Jun-Jie Zhang, Qian-Jin Zhang, Yang Dong, Zhen-Duo Shi, Si-Hao Hong, Hou-Guang He, Wei Wu, Cong-Hui Han, Lin Hao

Summary: Bladder cancer, the most common malignant tumor in the urinary system, is associated with significantly up-regulated expression of P3H4, which is regulated by METTL3 and plays a crucial role in the proliferation, metastasis, and EMT progression of bladder cancer. Targeting this METTL3-P3H4 pathway may serve as a potential therapeutic strategy for bladder cancer.

CELLULAR SIGNALLING (2024)